MILDRONATE 500 MG 60 CAPS - MADE IN LATVIA - FREE SHIPPING

Capsules "Mildronate" are used in complex therapy in the following cases:

diseases of the heart and vascular system: stable exertional angina, chronic heart failure (NYHA I-IIII functional class), cardiomyopathy, functional disorders of the heart and vascular system;

acute and chronic ischemic disorders of cerebral circulation;

decreased performance, physical and psycho-emotional overstrain;

during the recovery period after cerebrovascular disorders, head trauma and encephalitis.

Composition

The active ingredient is meldonium (one solid capsule contains 500 mg of meldonium).

Excipients: potato starch, silicon dioxide, calcium stearate.

Capsule (body and lid): titanium dioxide (E 171), gelatin.

Contraindications

hypersensitivity to meldonium and / or any excipient of the preparation ;

increased intracranial pressure (in violation of venous outflow, intracranial tumors);

severe hepatic and / or renal failure (there is insufficient data on the safety of use).

Mode of application

Apply internally. Due to the possible stimulating effect, the preparation is recommended to be used in the morning.

The daily dose for adults is 500-1000 mg, you can use the entire dose at one time or divide it into 2 doses. The maximum daily dose is 1000 mg.

The duration of the course of treatment is 4-6 weeks. The course of treatment can be repeated 2-3 times a year.

Application features

Pregnant

Animal studies are insufficient to assess the effects of meldonium on pregnancy, embryo / fetal development, childbirth and postpartum development. The potential risk to humans is unknown, therefore meldonium is contraindicated during pregnancy.

The available animal data indicate the penetration of meldonium into mother's milk. It is not known whether meldonium passes into human breast milk. The risk to newborns / infants cannot be excluded, therefore, during breastfeeding, meldonium is contraindicated.

Children

There are no data on the safety and efficacy of meldonium use in children under the age of 18, so the use of meldonium in this category of patients is contraindicated.

Overdose

No cases of meldonium overdose have been reported. The preparation is low-toxic and does not cause threatening side effects. With low blood pressure, headaches, dizziness, tachycardia, weakness are possible. Treatment is symptomatic. In case of severe overdose, it is necessary to monitor liver and kidney function. Hemodialysis is not essential in case of an overdose of meldonium due to the pronounced binding to blood proteins.

Side effects

Below are the side effects that have been observed in clinical studies and in the post-registration period.

From the immune system: often (≥ 1/100 to <1/10) - allergic reactions.

From the nervous system: often (≥ 1/100 to <1/10) - headaches.

From the respiratory, chest and mediastinal organs: often (≥ 1/100 to <1/10) - respiratory tract infections.

From the gastrointestinal tract: often (≥ 1/100 to <1/10) - dyspepsia.

Storage conditions

Store in its original packaging to protect from moisture at a temperature not exceeding 25 ° C, out of the reach of children.